Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects

Dementia and Geriatric Cognitive Disorders

Volumn 25, Issue 5, 2008, Pages 423-432

  Aho, Leena ^a   Parkkinen, Laura ^a   Pirttilä, Tuula ^a,b   Alafuzoff, Irina ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Synuclein; Amyloid; Alzheimer's disease; Hyperphosphorylated ; Immunohistochemistry, aging, dementia; Lewy body dementia; Postmortem brain; Striatum

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CORPUS STRIATUM; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; MALE; MIDDLE AGED; PHOSPHORYLATION; TAU PROTEINS;

EID: 43049126523     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000122963     Document Type: Article

References (35)

1. Baba M, Tomita T, Trojanowski JQ, Nakaya K, Nakajo S, Tu PH, Lee VM, Iwatsubo T: Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-884.
2. Braak H, Kretzschmar H, Del Tredici K, Alafuzoff I, Arzberger T: Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006;112:389-404.
3. Spillantini MG, Trojanowski JQ, Jakes R, Schmidt ML, Lee VM, Goedert M: Alpha-synuclein in Lewy bodies. Nature 1997;388:839-840.
4. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
5. Braak H, Del Tredici K, Rüb U, Rob AI, de Vos, Jansen Steur ENH, Braak E: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
6. McKeith IG, Perry EK, Salmon DP, Dickson DW, Galasko D, Kosaka K, Mirra SS, Hansen LA, Lowe J: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
7. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK: Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-139.
8. Thal DR, Braak H, Rüb U, Orantes M: Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002;58:1791-1800.
9. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS: Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006;66:1837-1844.
10. Davis DG, Markesbery WR, Schmitt FA, Wekstein DR: Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 1999;58:376-388.
11. Jellinger KA: Lewy body-related α-synucleinopathy in the aged human brain. J Neural Transm 2004;111:1219-1235.
12. McKee AC, Au R, Cabral HJ, Kowall NW, Seshadri S, Kubilus CA, Drake J, Wolf PA: Visual association pathology in preclinical Alzheimer's disease. J Neuropathol Exp Neurol 2006;65:621-630.
13. Neuropathology Group, Medical Research Council Cognitive Function and Aging Study: Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169-175.
14. Parkkinen L, Kauppinen T, Pirttilä T, Autere JM, Alafuzoff I: Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 2005;57:82-91.
15. Snowdon DA: Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist 1999;37:150-156.
16. Wakisaka Y, Iida M, Kiyohara Y, Furuta A, Tanizaki Y, Iwaki T: Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol 2003;106:374-382.
17. Parkkinen L, Pirttilä T, Tervahauta M, Alafuzoff I: Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject. Neuropathology 2005;25:304-314.
18. Jellinger K, Attems J: Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol 2006;112:253-260.
19. Wolf DS, Mori H, Markesbery WR, Gearing M, Snowdon DA, Mirra SS: Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis Assoc Disord 1999;13:226-231.
20. Aho L, Jolkkonen J, Alafuzoff I: Beta-amyloid aggregation in human brains with cerebrovascular lesions. Stroke 2006;37:2940-2945.
21. Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST: Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 2007;27:6174-6184.
22. Del Tredici K, Rub U, de Vos RAI, Bohl JRE, Braak H: Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002;61:413-426.
23. Hamilton RL: Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 2000;10:378-384.
24. Uchikado H, Lin W, DeLucia MW, Dickson DW: Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 2006;65:685-697.
25. Parkkinen L, Soininen H, Laakso M, Alafuzoff I: Alpha-synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol 2001;27:314-325.
26. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, Craft S, Leverenz JB, Montine TJ: Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007;62:406-413.
27. Klunk WE, Blomqvist G, Huang G, Wang Y, Bergström M, Engler H, Nordberg A, Holt DP, Savitcheva I: Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004;55:306-319.
28. Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, Irizarry MC, Klunk WE, Mathis CA, Dekosky ST, Greenberg SM, Hyman BT, Growdon JH: Molecular imaging with Pittsburgh compound B confirmed at autopsy: a case report. Arch Neurol 2007;64:431-434.
29. Harding AJ, Halliday GM: Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 2001;102:355-363.
30. Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE: Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000;54:1916-1921.
31. Mattila PM, Dickson DW, Röyttä M, Rinne JO, Helenius H: Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol 2000;100:285-290.
32. Braak H, Rüb U, Jansen Steur EN, Del Tredici K, de Vos RA: Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005;64:1404-1410.
33. Colosimo C, Hughes AJ, Kilford L, Lees AJ: Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003;74:852-856.
34. McKeith IG, O'Brien JT, Lippa C, Emre M, Cummings J, Dickson DW, Lowe J, Feldman H, Duda JE: Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005;65:1863-1872.
35. Liang T, Noorigian J, Duda J: Does striatal pathology distinguish DLB from PDD? Mov Disord 2006;21:S69-S70.